We're here to support your journey to quit smoking, one nicotine gum at a time.

Vectura Fertin Pharma Malaysia, is a company established in April 2023, is an affiliate of Vectura Fertin Pharma, which is developing and commercialising an innovative pipeline and differentiated brands focused on unmet consumer and patient needs in wellness and healthcare. Powered by its CDMO (contract development manufacturing organisation) business, the company is leveraging its deep expertise in inhalation and oral delivery systems to develop new products and revitalise existing therapies across four areas: Cannabinoids (in the pharmaceutical, medical and consumer wellness segments), Consumer Health, Nicotine Replacement Therapy, and Inhaled Therapeutics. Underpinned by scientific substantiation and rigour, and patient and consumer insights, the company is committed to finding new and better ways to improve life. Vectura Fertin Pharma was created in 2022 following the acquisition of Fertin Pharma, Vectura Group PLC and OtiTopic by Philip Morris International.